Heart valve study pulled before it even started
NCT ID NCT04636073
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study was designed to test a device called Leaflex Performer for people with severe aortic stenosis, a condition where the heart's aortic valve becomes narrow. The goal was to see if the device could safely improve valve function without needing surgery or a new valve. However, the study was withdrawn before any participants were enrolled, so no results are available.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single stitch beat a double closure for TAVI patients?
- Can a fitness app boost recovery after heart valve replacement?
- A new heart valve without Open-Heart surgery: can it help High-Risk patients?
- Can a single antiplatelet drug beat aspirin after heart valve replacement?
- Can common heart-surgery practices trigger delirium? a 5,600-patient hunt for clues.
- Which heart valve works best for small aortic openings? a Head-to-Head trial